MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12987-026-00818-1

Медицинская библиотека · Fluids and barriers of the CNS · 2026

Convergent blood-brain barrier breakdown in schizophrenia and autism spectrum disorders: a systematic review of preclinical animal models.

Morente-Montilla Cristina, Fernández-Guillén María, Gómez-Garrido Ana, García-Cerro Susana, Moreno-Mellado Amanda, Campbell Matthew, Soreq Hermona, Greenberg David S, Deli Maria A, Crespo-Facorro Benedicto, Martín-Cuevas Celia, Riga Maurizio S

СтатьяСистематический обзорПеревод в очереди

Аннотация

BACKGROUND

Schizophrenia (SCZ) and autism spectrum disorder (ASD) are neurodevelopmental disorders with multifactorial origins involving genetic and environmental risk factors. Both conditions share overlapping pathophysiological mechanisms, including neuroinflammation, synaptic dysfunction, and circuit-level disturbances. Emerging evidence implicates blood-brain barrier (BBB) dysfunction as a potential common element in their pathogenesis. Specifically, BBB disruption is a recurring feature in preclinical models of SCZ and ASD, suggesting its role as a transdiagnostic mechanism in neurodevelopmental disorders. This systematic review aims to evaluate BBB alterations-including permeability, integrity, developmental changes, and tight junction (TJ) protein expression-in rodent models of SCZ- and ASD-like phenotypes.

METHODS

Following PRISMA guidelines, we screened experimental studies assessing BBB status in murine models of SCZ and ASD compared to wild type rodents. Inclusion criteria focused on models based on genetic manipulation and environmental insults. Included studies consistently reported BBB alterations across diverse models.

RESULTS

Findings showed disrupted TJ protein expression (claudin-5, occludin, ZO-1), increased permeability, and endothelial dysfunction. Both genetic (e.g., Shank3, 22q11.2 deletion, etc.) and environmental (e.g., maternal immune activation, valproate exposure, etc.) models exhibited BBB abnormalities. Pharmacological and experimental interventions targeting the BBB-such as claudin-5 modulation or β-catenin signaling-ameliorated BBB damage and behavioral phenotypes.

CONCLUSIONS

That BBB disruption is a recurring feature in preclinical models of SCZ and ASD suggests its pursuit as a transdiagnostic mechanism in neurodevelopmental disorders. However, as many findings rely on single studies, further replication is essential. Future studies should explore sex differences, critical developmental windows, and therapeutic strategies aimed at restoring BBB function.

Для цитирования: Morente-Montilla Cristina, Fernández-Guillén María, Gómez-Garrido Ana, García-Cerro Susana, Moreno-Mellado Amanda, Campbell Matthew, Soreq Hermona, Greenberg David S, Deli Maria A, Crespo-Facorro Benedicto, Martín-Cuevas Celia, Riga Maurizio S. Convergent blood-brain barrier breakdown in schizophrenia and autism spectrum disorders: a systematic review of preclinical animal models.. Fluids and barriers of the CNS. 2026. DOI: 10.1186/s12987-026-00818-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.